临床经验
Copyright ©The Author(s) 2015.
世界华人消化杂志. 2015-06-08; 23(16): 2654-2659
在线出版 2015-06-08. doi: 10.11569/wcjd.v23.i16.2654
表1 影响中低位直肠癌患者术前放化疗预后的Logrank法单因素分析
因素nOS
DFS
LRFS
DMFS
例数(n)χ2例数(n)χ2例数(n)χ2例数(n)χ2
性别0.7910.4111.9050.187
42326812
302061010
年龄(岁)1.8140.1780.0740.040
<6038307912
≥6034225910
距肛缘(cm)1.1080.4000.2960.262
≤5362871012
>536245810
肿瘤直径(cm)0.6040.0450.3000.013
≤532245710
>5402871112
T分期2.5000.6830.3301.013
T22820366
T330242810
T4148246
N分期0.2210.4050.3000.131
N032245910
N(+)期40287912
TRG分级10.651a3.54429.908a31.905a
1级202061416
2-5级5232646
降期37.644a5.5389.231a5.514a
5248121820
204002
术后病理分期10.471a11.520a7.500a8.849a
0-Ⅱ期4035121518
Ⅲ-Ⅳ期3217034
阳性淋巴结数(个)8.861a7.2005.333a8.378a
0-34840121620
≥42412022
表2 影响中低位直肠癌患者预后的Cox风险模型分析
影响因素βS.EWaldOR(95%CI)P
阳性淋巴结个数
OS1.7720.9127.0255.669(1.589-8.123)0.000
DFS1.5250.8855.1234.986(1.232-7.025)0.000
LRFS1.4210.9026.1254.223(1.269-6.425)0.000
DMFS1.4080.8676.2234.112(1.326-6.986)0.002
术后病理分期
OS1.3780.8455.3964.692(1.485-7.021)0.000
DFS1.3450.8365.7023.982(1.356-8.021)0.004
LRFS1.3140.8125.6983.752(1.112-7.112)0.008
DMFS-----
术后降期
OS1.2850.8025.5423.725(1.086-6.893)0.010
DFS1.2790.7565.4433.569(1.228-7.223)0.011
LRFS1.2720.7395.3693.498(1.152-7.311)0.015
DMFS-----
表3 根据危险因素分组的患者不同预后情况及复发率比较 n(%)
危险因素分组nOSDFSLRFSDMFS复发率
Ⅰ组 12 12(100.00) 8(66.67) 4(33.33) 0(0.00) 1(8.33)
Ⅱ组 18 14(77.78) 4(22.22) 8(44.44) 2(11.11) 4(22.22)
Ⅲ组 24 14(58.33) 0(0.00) 0(0.00) 14(58.33) 12(50.00)
Ⅳ组 18 8(44.44) 0(0.00) 2(0.00) 6(33.33) 14(77.78)
合计 72 52(72.22) 12(16.67) 18(25.00) 22(30.55) 31(43.05)
χ211.750 30.400 15.251 17.280 18.411
P0.008 0.000 0.002 0.001 0.000

引文著录: 马金国, 张冰, 常晓静. 术前放化疗对局部进展期中低位直肠癌患者外科治疗效果的影响. 世界华人消化杂志 2015; 23(16): 2654-2659